Reckitt Invests Up to $600 Million to Accelerate U.S.-based Innovation, Expand Access to Healthcare Products, and Strengthen Supply Resilience

NUTLEY, N.J., SEPTEMBER 16, 2026 – Reckitt today announced up to a $600 million, multi-year transformation of its U.S. operations across two sites to accelerate the long-term growth of its U.S. business. Investments will include relocation and integration of its commercial and R&D capabilities into a campus in New Jersey and significantly expanded plans for its largest over-the-counter (OTC) manufacturing facility in North Carolina.

These phased investments aim to fast-track innovation, sharpen responsiveness to evolving consumer needs, and strengthen supply resilience to ensure reliable access to essential healthcare products. Reckitt employs more than 4,000 employees at seven manufacturing sites and three science and innovation centers across the United States.

Reckitt recently relocated its North American campus in New Jersey to support commercial and operational teams. As the next phase of development, the company will break ground on a new state-of-the-art science and innovation center with best-in-class capabilities in disinfection, microbiology, surface care, laundry care and personal care.

This flagship germ protection hub within Reckitt’s global R&D network will be pivotal in advancing Reckitt’s portfolio, including Lysol. At the center of this transformation is a new model for innovation that brings together world-class R&D, advanced scientific capabilities, and commercial expertise to speed the path from concept to shelf.

Reckitt has doubled its initial investment for its state-of-the art OTC manufacturing facility in North Carolina. The site will become its largest OTC manufacturing facility in the U.S. with additional funding supporting expanded production capacity for Mucinex® tablets and liquids, as well as increased production volumes for Move Free®. The site will open in the first half of 2027. This investment also significantly expands the facility’s physical footprint, creating the space needed to support future growth, enhance manufacturing flexibility, and accommodate new capabilities as demand evolves.

On November 19, the company will be hosting its first Reckitt Focus On event in the United States, where Jérôme Lemaire and other U.S. leaders will showcase the North America business. To register your interest in joining us, please use the following link: event.swisscom.ch/v/northamerica.

About Reckitt

We make the products people trust to care for the ones they love. We are home to some of the world’s best-loved consumer health and hygiene brands, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By creating innovative, science-backed solutions, we support people every day to live healthier lives.

Reckitt exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. This commitment goes beyond the products we make. Through our actions, we expand access to healthcare, education and economic opportunities. We support the planet by reducing waste, conserving resources and driving sustainable innovation.

We believe good health starts at home. With every action we take, we strive to make our consumers’ lives easier, cleaner and healthier, to strengthen communities and to create a more sustainable future. Find out more or get in touch with us at Reckitt.com/us.

Reckitt is the trading name of the Reckitt group of companies